The development of therapies for mainstream and established diseases is fairly complex, but for rare diseases, these challenges are often...
Read More...
The post Spinal Muscular Atrophy and the challenges of funding rare diseases appeared first on Pharmaceutical Technology.
Original Article: Spinal Muscular Atrophy and the challenges of funding rare diseases